[Determination of plasma prolactin in patients with breast dysplasia].
Prolactin is determined by means of radioimmunoassay in the postovulatory phase of a group of women with mammary dysplasia. A specially increased concentration of prolactin is found in the proliferative dysplasias (multiple intraductal papillomatosis and invasive sclerosing adenosis), that may be considered as preneoplastic processes.
D001943:Breast Neoplasms / Q000097:blood; D004967:Estrogens / Q000097:blood; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood* / Q000145:classification / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D008183:Luteal Phase; D010212:Papilloma / Q000097:blood; D011230:Precancerous Conditions / Q000097:blood* / Q000145:classification / Q000473:pathology; D011374:Progesterone / Q000097:blood; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay; D012306:Risk
D004967:Estrogens; D011374:Progesterone; D011388:Prolactin
Determinación de prolactina plasmática en pacientes afectas de displasia mamaria.